Century Therapeutics officer plans 534-share sale
An officer of Century Therapeutics filed a Rule 144 notice to sell 534 IPSC shares, partly to cover taxes from a vested equity award.
Rhea-AI Filing Summary
Century Therapeutics, Inc. (IPSC) has a notice of proposed sale of common stock under Rule 144 by officer Gregory Russotti. The notice covers the planned sale of 534 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ. The filer also reports prior sales in the last three months, and notes that the transaction includes shares sold to satisfy a tax obligation arising from the settlement of a vested equity award.
Positive
- None.
Negative
- None.
Key Figures
Shares proposed to be sold: 534 shares
Aggregate market value of proposed sale: $1,094.43
Shares sold June 8, 2026: 524 shares
+4 more
7 metrics
Shares proposed to be sold
534 shares
Rule 144 sale of Century Therapeutics, Inc. common stock
Aggregate market value of proposed sale
$1,094.43
Value listed for 534 IPSC shares in the Rule 144 notice
Shares sold June 8, 2026
524 shares
Prior IPSC common stock sale reported in last three months
Proceeds June 8, 2026 sale
$1,106.01
Aggregate amount for 524 IPSC shares sold June 8, 2026
Shares sold June 12, 2026
2,584 shares
Second IPSC common stock sale reported in last three months
Proceeds June 12, 2026 sale
$5,767.75
Aggregate amount for 2,584 IPSC shares sold June 12, 2026
Date of Rule 144 notice
September 8, 2026
Date the Form 144 notice was filed
Key Terms
Rule 144, Restricted Stock Vesting, vested equity award, attorney-in-fact
4 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Vesting financial
"Common | 09/04/2026 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
vested equity award financial
"resulting from the settlement of a vested equity award distribution"
attorney-in-fact regulatory
"as attorney-in-fact for Gregory Russotti"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
FAQ
What insider transaction did IPSC disclose in this Form 144 filing?
The filing reports a proposed Rule 144 sale by officer Gregory Russotti of 534 shares of Century Therapeutics, Inc. common stock through Fidelity Brokerage Services LLC on NASDAQ, with part of the sale intended to cover taxes from a vested equity award.
AI-generated analysis. How Rhea-AI works. Not financial advice.